Γ

Hands on: AI-Bio Masterclass

Learn from experts how to leverage AI to build with biology faster and cheaper
May 4-7

2026

San Jose Convention Center
California, USA

May 4-7

2026

San Jose Convention Center

California, USA

If your organization isn’t actively integrating AI into its workflows, you are falling behind. AI first companies are eclipsing the old wave and entering the market at an accelerated rate. This is your opportunity to catch up. Join us for a masterclass on AI for Biology.

During our AI and Bio Masterclass, you’ll have the opportunity to work 1 : 1 with the scientists, engineers, and product leaders driving AI adoption across the bioeconomy.

Over the course of our 3-day workshop, you'll learn how to translate real R&D challenges into structured AI workflows, use cutting-edge generative models to design and optimize proteins, enzymes, and pathways, and build AI-integrated experimental loops that accelerate validation and iteration across therapeutics, chemicals, materials, and food.

Wherever you are in your AI journey, our experts will guide you through practical, hands-on workflows that meet you at your current level and help you confidently apply these tools to your own R&D.

AI-Enabled Design & Discovery


Many teams struggle to explore massive sequence spaces that are impossible to search by hand. Experimental data is often sparse or inconsistent, making it hard to trust intuition alone. Stability, activity, and manufacturability predictions frequently break down when moving from in silico ideas to real-world systems.


  • Use generative models to propose novel protein and enzyme designs.


  • Score and prioritize variants for stability, activity, and manufacturability.


  • Uncover design opportunities impossible to find manually.

AI-Integrated Workflows & Data Infrastructure


Most teams struggle with scattered data and workflows that aren’t designed for AI. Experiments, assays, and fermentation runs often live in isolated systems, making it hard to create clean datasets or connect model outputs back to the bench.


  • Structure and standardize biological data so AI tools work reliably.

  • Connect ELNs, LIMS, models, and lab systems into a unified workflow.

  • Automate data capture and build reproducible AI-enabled experiment loops.

AI-Driven Experimentation & Optimization


R&D teams often run slow, linear experimentation that can’t keep up with growing design spaces or rapidly changing program needs. It’s hard to know which variants, conditions, or pathways to test first—and even harder to connect early data to meaningful optimization.

  • Use AI to propose, rank, and plan the next best experiments.


  • Apply model-guided DOE for fermentation, optimization, and scale-up.


  • Build closed-loop workflows that accelerate validation and iteration.


The future of biology is programmable — powered by AI, shaped by collaboration, and built for healthy humans and a sustainable planet.

Confirmed Speakers

Sessions will include:

1

Beyond Static Predictions — AI for Protein Dynamics and Multi-Cell Models

The next frontier of biology isn’t in predicting a single static protein structure, but in capturing how proteins move, fold, and interact across time and environments. This session explores how AI can illuminate protein conformations and dynamics, and extend those insights into virtual multi-cellular or tissue models. Experts will discuss the challenge of integrating heterogeneous datasets and instruments, and how breakthroughs in dynamic modeling could reshape drug design, disease understanding, and biomanufacturing. Can we build models that reflect the living, breathing complexity of biology—not just snapshots, but motion?

[…]

1

Beyond Static Predictions — AI for Protein Dynamics and Multi-Cell Models

The next frontier of biology isn’t in predicting a single static protein structure, but in capturing how proteins move, fold, and interact across time and environments. This session explores how AI can illuminate protein conformations and dynamics, and extend those insights into virtual multi-cellular or tissue models. Experts will discuss the challenge of integrating heterogeneous datasets and instruments, and how breakthroughs in dynamic modeling could reshape drug design, disease understanding, and biomanufacturing. Can we build models that reflect the living, breathing complexity of biology—not just snapshots, but motion?

[…]

2

The Data Reality Check: Human-First Biology for AI Models

Why do so many in silico models fail when moved to the lab or clinic? Too often, they’re trained on incomplete, non-human, or non-representative datasets. This session tackles the “data gap” head-on: from interoperability bottlenecks and the black box problem to the limits of current virtual cell simulations (~50 million perturbations vs. the billions biology demands). Panelists will explore how to create “human-first” datasets that reflect real biology, unlock mechanistic interoperability, and close the discovery–development divide. The goal: build AI tools that can directly identify viable drug candidates instead of stalling in silico.

[…]

2

The Data Reality Check: Human-First Biology for AI Models

Why do so many in silico models fail when moved to the lab or clinic? Too often, they’re trained on incomplete, non-human, or non-representative datasets. This session tackles the “data gap” head-on: from interoperability bottlenecks and the black box problem to the limits of current virtual cell simulations (~50 million perturbations vs. the billions biology demands). Panelists will explore how to create “human-first” datasets that reflect real biology, unlock mechanistic interoperability, and close the discovery–development divide. The goal: build AI tools that can directly identify viable drug candidates instead of stalling in silico.

[…]

3

4

Programmable Molecules: AI and the Rise of Context-Aware Therapeutics

For the first time, AI is enabling us to imagine medicines that “think” - turning on only inside diseased cells or under specific physiological conditions. Neural networks trained on RNA, protein, and cellular data are unlocking a new generation of programmable therapies with unprecedented precision, from cancer drugs that remain inert until encountering tumor signals to RNA medicines capable of adapting to dynamic biological environments. But designing intelligent molecules is only part of the challenge. As AI expands the space of possible therapeutics, the field must also confront a critical question: how do we reliably build, test, and manufacture increasingly complex biological designs? This session explores the emerging continuum from AI-designed molecules to manufacturable programmable therapeutics, examining how advances in sequence design, synthesis, delivery, and validation are translating computational insight into real-world medicines. The future of medicine isn’t static molecules - it’s intelligent, adaptive therapeutics engineered across the full stack, from algorithm to clinic.

[…]

4

Programmable Molecules: AI and the Rise of Context-Aware Therapeutics

For the first time, AI is enabling us to imagine medicines that “think” - turning on only inside diseased cells or under specific physiological conditions. Neural networks trained on RNA, protein, and cellular data are unlocking a new generation of programmable therapies with unprecedented precision, from cancer drugs that remain inert until encountering tumor signals to RNA medicines capable of adapting to dynamic biological environments. But designing intelligent molecules is only part of the challenge. As AI expands the space of possible therapeutics, the field must also confront a critical question: how do we reliably build, test, and manufacture increasingly complex biological designs? This session explores the emerging continuum from AI-designed molecules to manufacturable programmable therapeutics, examining how advances in sequence design, synthesis, delivery, and validation are translating computational insight into real-world medicines. The future of medicine isn’t static molecules - it’s intelligent, adaptive therapeutics engineered across the full stack, from algorithm to clinic.

[…]

5

6

Previous sponsors & exhibitors

Previous Participants

Past Conference Highlights

Join for the latest SynBioBeta event updates.